Clinical trials: RT-PCR
SARS-CoV-2
Dry Versus Wet Nasopharyngeal Rapid Test for the Detection of COVID-19.
Saliva sampling could serve as an alternative non-invasive sample for SARS-CoV-2 diagnosis while rapid antigen testing (RAT) might help to mitigate the shortage of reagents sporadically encountered with RT-PCR.
- Trial name
- RESTART (NCT04839094)
- Testing
- rapid antigen testing versus RT-PCR
- Where
- Switzerland
- Volunteers
- 58 people
- Sponsor
- Centre Hospitalier Universitaire Vaudois
Lassa Fever
ARN-75039 Lassa Fever Treatment in West Africa
This multicenter, randomized, open-label Phase 2 clinical trial evaluates the safety, tolerability, and virologic efficacy of ARN-75039, a novel oral antiviral, for treating Lassa fever in hospitalized adults in West Africa.
- Trial name
- NCT07419373
- Testing
- ARN-75039 high, Intravenous ribavirin, ARN-75039 low
- Where
- 4 sites in United States, Nigeria
- Volunteers
- 135 people
- Sponsor
- Arisan Therapeutics, Inc.